Back
Gilead Sciences Stock Predictions
Sell
32
GILD
Gilead Sciences
Last Price:
67.01
Seasonality Move:
6.01%
7 Day Trial
ALL ACCESS PASS
$
7
Gilead Sciences Stock Forecast
- Over the next 52 weeks, Gilead Sciences has on average historically risen by 22.7% based on the past 32 years of stock performance.
- Gilead Sciences has risen higher in 22 of those 32 years over the subsequent 52-week period, corresponding to a historical accuracy of 68.75%
-
Is Gilead Sciences Stock Undervalued?
The current Gilead Sciences [GILD] share price is $67.65. The Score for GILD is 32, which is 36% below its historic median score of 50, and infers higher risk than normal. - GILD is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Gilead Sciences Stock Go Up Next Year?
- Over the next 52 weeks, Gilead Sciences has on average historically risen by 22.7% based on the past 32 years of stock performance.
Gilead Sciences Stock Rating
Sell
32
Gilead Sciences (GILD)
is a Sell
Is Gilead Sciences overpriced?
- Gilead Sciences has risen higher in 22 of those 32 years over the subsequent 52-week period, corresponding to a historical accuracy of 68.75%
Gilead Sciences Stock Price History
Stock Information
Stock Info
Exchange:
S&P500
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
gilead.com
52-Week Data
52-Week High:
87.87
52-Week Low:
64.33
Prediction Charts
Market Cap:
84.28B
Price in USD:
67.65
Volume:
4.31M
Beta:
0.76
Technical Analysis
SMA50:
69.61
SMA100:
74.05
SMA200:
75.63
52-Wk Change:
-13.46%
Stock Predictions
-
Is Gilead Sciences stock public?
Yes, Gilead Sciences is a publicly traded company. -
What is the Gilead Sciences stock quote today?
The Gilead Sciences stock price is 67.65 USD today. -
How to buy Gilead Sciences stock online?
You can buy Gilead Sciences shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Apr-25 | 67.47 | 65.27 | 67.90 | 65.09 |
Apr-26 | 65.50 | 65.42 | 66.35 | 64.63 |
Apr-29 | 65.30 | 65.94 | 66.91 | 65.20 |
Apr-30 | 65.62 | 65.19 | 65.64 | 64.82 |
May-1 | 65.32 | 65.51 | 65.89 | 64.97 |
May-2 | 65.75 | 65.33 | 65.80 | 64.89 |
May-3 | 65.51 | 64.78 | 65.53 | 64.33 |
May-6 | 64.78 | 65.55 | 65.56 | 64.34 |
May-7 | 65.43 | 65.43 | 66.14 | 65.16 |
May-8 | 65.57 | 64.92 | 65.61 | 64.76 |
May-9 | 65.18 | 64.60 | 65.22 | 64.52 |
May-10 | 64.72 | 65.96 | 66.20 | 64.67 |
May-13 | 66.15 | 67.54 | 67.59 | 66.13 |
May-14 | 68.00 | 67.65 | 68.37 | 67.05 |
Gilead Sciences Earnings
Gilead Sciences Earnings Report: Per Share Gilead Sciences Earnings Q1 Q2 Q3 and Q4 last year and next year.
Gilead Sciences Forecast Revenue Growth
Gilead Sciences Stock Analysis: Historical quarterly revenues per share for Gilead Sciences and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.00 per share, and an increase next year of $3.41 per share.
* Gilead Sciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.